Stay updated with breaking news from Diana isaacs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GLP-1 receptor drugs, like Mounjaro, may hinder the effectiveness of oral contraceptives. It's recommended that people taking Mounjaro switch to a non-oral birth control method, or add a barrier method of contraception in the timeframe around a dose of the GLP-1 drug. ....
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a monthly podcast hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP, aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. ....
Our endocrinology month in review for September 2023 spotlights news related to semaglutide and a pair of articles offering a deep dive into comorbidities in type 1 and type 2 diabetes. ....
Diana Isaacs, PharmD, and Natalie Bellini, DNP, provide a breakdown of the latest news in diabetes management, including FDA clearance of a new insulin pump and a major acquisition within the diabetes world. ....
In this episode, hosts sit down for a discussion around a recent NEJM report assessing the effects of semaglutide use in people with type 1 diabetes, including the implications of the findings and their real-world experiences with GLP-1 use in people with type 1 diabetes. ....